北京招聘

We are dedicated to transforming the way in which patients with cancer are diagnosed and treated. At GenomiCare you will work with everyone fighting the disease—patients and their families, scientists, physicians, drug developers—to raise awareness about the ongoing evolution in cancer care and to ensure we are delivering the analytic tools and molecular information required to bring the promise of personalized cancer care into routine clinical practice. As a member of our Medical Affairs department, you will be responsible for distilling the latest advances in genomic science, oncology, technology and clinical data into innovative, best-in-class clinical tools and products that will enable oncologists to determine the best treatment throughout each patient's journey with cancer.

Job Description

1、 Medical review of genomic testing reports, patients’ medical data, case reports, clinical trial data, etc.

2、Medical consultation on genomic testing reports to patients or physicians, consultation on cancer treatments, and facilitating remote-second-opinion

3、Working with technical team to build up clinical database as needed

4、 Contribute to publications as needed

5、Medical support to other sectors, including but not limited to marketing, branding and strategic development

Qualifications

1、 MS or MD degree in medical oncology and minimum 2 years’ clinical practice

2、Specific knowledge about diagnoses and treatments of common malignant solid tumors, such as lung cancer, colorectal cancer, liver cancer, and CNS tumors.

3、 Basic knowledge about molecular medicine and cancer targeted therapy or immunotherapy

4、English listening、reading、writing and translation in specific field

5、Good communication skills

Other Information

1、 Position is full-time

2、 Business trip and attending meeting when necessary

领星隶属嘉信医疗服务集团（Carebridge Holdings），由中美生物医学科学家携手资深肿瘤专家共同开创的肿瘤精准医疗服务及科研平台，并与集团旗下的上海嘉会国际医院及《NEJM医学前沿》共同打造医学研三位一体的医疗生态系统。

领星旗下有两个子公司，领星医学通过临床全外显子组测序，多组学检测及定制化ctDNA监测等核心产品，将最新的基因测序技术应用到临床，为医生和患者提供肿瘤精准治疗方案筛选、实施和监测服务，致力于推动中国肿瘤个体化精准医疗的发展。

领星生物基于中国***规模的肿瘤临床全外显子组数据库, 通过整合多源异构医疗数据，利用人工智能等相关技术，前瞻性地整合肿瘤基因组数据和每位患者完整的临床路径，打造“基因+临床”精准医疗数据库，并结合其***的数据驱动算法，为制药行业合作伙伴提供Best-in-class的真实世界数据临床解决方案，积极推动肿瘤精准药物研发的发展。